WAVE Life Sciences Ltd to Host Analyst and Investor Research Day Transcript
(presentation)
And first and foremost, welcome. Thank you for taking the time out of all of your day. For everyone in this room, I'm grateful. We're grateful. I know you all have busy schedules, so we appreciate you spending some time with us to learn about what's happening at Wave. To those of you who are logged on to the webcast, we appreciate you taking the time out of your day as well and we hope to have it to be a productive one.
To make it productive, we'll quickly talk about some forward-looking statements. We will be making forward-looking statements during this presentation. So again, please refer to our SEC filings for current updates.
And with that said, I know many of you are here eagerly awaiting our clinical data for duchenne muscular dystrophy, our exon 51 suvodirsen program as well as our HD program. We are too. And it's important for you all to know that we remain on track for delivering that data this year. We anticipate delivering the suvodirsen biopsy data from our ongoing open-label
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
